Tropoflex Inc.

SEC filing

Biotechnology · San Antonio, TX

Form D on EDGAR

Amount raised$250Ksold at filing

Total offering$2.5M$2.3M still open

Investors in the raise1count reported to the SEC

FiledSep 22, 2025first sale Sep 10, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Kevin MeehanDirector

Kristen ParkerDirector

Bryan DanielsDirector

Paul CastellaExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.